480 related articles for article (PubMed ID: 33140521)
1. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
[TBL] [Abstract][Full Text] [Related]
2. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.
Cipriani P; Di Benedetto P; Ruscitti P; Verzella D; Fischietti M; Zazzeroni F; Liakouli V; Carubbi F; Berardicurti O; Alesse E; Giacomelli R
Arthritis Res Ther; 2015 Sep; 17(1):247. PubMed ID: 26357964
[TBL] [Abstract][Full Text] [Related]
3. Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.
Cantanhede IG; Liu H; Liu H; Balbuena Rodriguez V; Shiwen X; Ong VH; Denton CP; Ponticos M; Xiong G; Lima-Filho JL; Abraham D; Abu-Hanna J; Taanman JW
Front Immunol; 2022; 13():1004949. PubMed ID: 36304460
[TBL] [Abstract][Full Text] [Related]
4. The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis.
Henderson J; Dayalan Naidu S; Dinkova-Kostova AT; Przyborski S; Stratton R; O Reilly S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440821
[TBL] [Abstract][Full Text] [Related]
5. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
6. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
7. Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation.
Bernard K; Logsdon NJ; Benavides GA; Sanders Y; Zhang J; Darley-Usmar VM; Thannickal VJ
J Biol Chem; 2018 Jan; 293(4):1218-1228. PubMed ID: 29222329
[TBL] [Abstract][Full Text] [Related]
8. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis.
Hegner B; Schaub T; Catar R; Kusch A; Wagner P; Essin K; Lange C; Riemekasten G; Dragun D
PLoS One; 2016; 11(4):e0153101. PubMed ID: 27054717
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis.
Higuchi T; Kawaguchi Y; Takagi K; Tochimoto A; Ota Y; Katsumata Y; Ichida H; Hanaoka M; Kawasumi H; Tochihara M; Yamanaka H
Clin Immunol; 2015 Dec; 161(2):333-8. PubMed ID: 26387628
[TBL] [Abstract][Full Text] [Related]
13. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
14. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition.
Watanabe T; Baker Frost DA; Mlakar L; Heywood J; da Silveira WA; Hardiman G; Feghali-Bostwick C
Genes (Basel); 2019 Jan; 10(2):. PubMed ID: 30678304
[No Abstract] [Full Text] [Related]
15. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis].
Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis.
Rozier P; Maumus M; Bony C; Maria ATJ; Sabatier F; Jorgensen C; Guilpain P; Noël D
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202139
[TBL] [Abstract][Full Text] [Related]
18. Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis.
Henderson J; Brown M; Horsburgh S; Duffy L; Wilkinson S; Worrell J; Stratton R; O'Reilly S
Rheumatology (Oxford); 2019 Mar; 58(3):527-535. PubMed ID: 30462328
[TBL] [Abstract][Full Text] [Related]
19. Alpinetin Suppresses Effects of TGF-β1 on Stimulating the Production and Organization of Fibrotic Markers in Human Primary Dermal Fibroblasts.
Wikan N; Potikanond S; Nimlamool W
Cells; 2022 Sep; 11(17):. PubMed ID: 36078140
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of skin fibrosis in systemic sclerosis.
Jinnin M
J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
